These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
101 related articles for article (PubMed ID: 12669044)
1. India sets its sights on global health care market. Jayaraman KS Nat Med; 2003 Apr; 9(4):377. PubMed ID: 12669044 [No Abstract] [Full Text] [Related]
2. Clinical trials in India: balancing economic opportunity with the public health context. Dandona L Natl Med J India; 2006; 19(2):57-9. PubMed ID: 16756189 [No Abstract] [Full Text] [Related]
3. Industry sponsored bias in cost effectiveness analyses. John-Baptiste A; Bell C BMJ; 2010 Oct; 341():c5350. PubMed ID: 20943724 [No Abstract] [Full Text] [Related]
4. India's growing clinical research sector: opportunity for global companies. Varawalla N IDrugs; 2007 Jun; 10(6):391-4. PubMed ID: 17642002 [TBL] [Abstract][Full Text] [Related]
5. Biopharmaceutical process development - shortcut to market: an interview with Rolf Werner from Boehringer Ingelheim. Jungbauer A; Göbel U Biotechnol J; 2012 Jan; 7(1):14-6. PubMed ID: 22228694 [No Abstract] [Full Text] [Related]
6. India's drug tests. Padma TV Nature; 2005 Jul; 436(7050):485. PubMed ID: 16049471 [No Abstract] [Full Text] [Related]
7. [Economic benefit and ethical challenges]. Riska O Tidsskr Nor Laegeforen; 2008 Sep; 128(17):1990. PubMed ID: 18800394 [No Abstract] [Full Text] [Related]
8. Clinical trials: the pitfalls of interpretation. Lokhandwalla Y; Dalvi B Issues Med Ethics; 1998 Apr; 6(2):47-8. PubMed ID: 15011700 [No Abstract] [Full Text] [Related]